Danaher Corporation (LON:0R2B)
London
· Delayed Price · Currency is GBP · Price in USD 203.06
+1.15 (0.57%)
At close: Jul 3, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Former Life Sciences | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Former Life Sciences Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics | 9.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Growth | -0.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Environmental & Applied Solutions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Environmental & Applied Solutions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biotechnology | 6.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biotechnology Growth | 0.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences | 7.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Growth | 1.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Recurring | 19.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Recurring Growth | 3.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Non-Recurring | 4.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Non-Recurring Growth | -9.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -35.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Former Life Sciences Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Former Life Sciences Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income | 2.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income Growth | -1.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Environmental & Applied Solutions Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Environmental & Applied Solutions Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -35.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biotechnology Operating Income | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biotechnology Operating Income Growth | 9.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Operating Income | 879.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Operating Income Growth | -24.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
North America | 10.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 1.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Europe | 5.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Europe Growth | 2.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Developed Markets | 1.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Developed Markets Growth | -1.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High-Growth Markets | 6870000000.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High-Growth Markets Growth | -1.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Core Sales Growth | -1.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Core Sales Growth Ex-Cytiva | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|